SLC2A5 and Other metabolic disease: Future research should focus on elucidating the precise molecular pathways and regulatory mechanisms driving GLUT5 overexpression in different cancer types, understanding GLUT5’s role in fructose-related metabolic disorders, exploring pharmacological interventions, and translating these findings into practical applications for improved healthcare.